James Sollins
Directeur/Bestuurslid bij Armune BioScience, Inc.
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Susan J. Crookston | F | - |
Armune BioScience, Inc.
 Armune BioScience, Inc. Medical/Nursing ServicesHealth Services Armune BioScience, Inc. researches and develops diagnostic and prognostic tests for prostate, lung, and breast cancers that may allow physicians and patients to make more personalized treatment decisions for a better prognosis. The firm's technology is based on evidence that the immune system’s early warning signals provide critical biological insight to improve cancer detection and enhance therapeutic effectiveness. The company was founded by Eli L. Thomssen in 2008 and is headquartered in Kalamazoo, MI. | 10 jaar |
| David A. Esposito | M | 55 |
Armune BioScience, Inc.
Armune BioScience, Inc. Medical/Nursing ServicesHealth Services Armune BioScience, Inc. researches and develops diagnostic and prognostic tests for prostate, lung, and breast cancers that may allow physicians and patients to make more personalized treatment decisions for a better prognosis. The firm's technology is based on evidence that the immune system’s early warning signals provide critical biological insight to improve cancer detection and enhance therapeutic effectiveness. The company was founded by Eli L. Thomssen in 2008 and is headquartered in Kalamazoo, MI. | 9 jaar |
| Donald Parfet | M | 71 |
Armune BioScience, Inc.
Armune BioScience, Inc. Medical/Nursing ServicesHealth Services Armune BioScience, Inc. researches and develops diagnostic and prognostic tests for prostate, lung, and breast cancers that may allow physicians and patients to make more personalized treatment decisions for a better prognosis. The firm's technology is based on evidence that the immune system’s early warning signals provide critical biological insight to improve cancer detection and enhance therapeutic effectiveness. The company was founded by Eli L. Thomssen in 2008 and is headquartered in Kalamazoo, MI. | - |
| James S. Arthurs | M | - |
Armune BioScience, Inc.
Armune BioScience, Inc. Medical/Nursing ServicesHealth Services Armune BioScience, Inc. researches and develops diagnostic and prognostic tests for prostate, lung, and breast cancers that may allow physicians and patients to make more personalized treatment decisions for a better prognosis. The firm's technology is based on evidence that the immune system’s early warning signals provide critical biological insight to improve cancer detection and enhance therapeutic effectiveness. The company was founded by Eli L. Thomssen in 2008 and is headquartered in Kalamazoo, MI. | - |
| F. Wimbush | M | 68 |
University of Virginia Law School Foundation
| - |
| Barbara Jeremiah | F | 72 |
University of Virginia Law School Foundation
| - |
| Alan C. Levitan | M | 81 |
Arts Council of the Morris Area
| - |
| Gil Omenn | M | 83 |
Armune BioScience, Inc.
Armune BioScience, Inc. Medical/Nursing ServicesHealth Services Armune BioScience, Inc. researches and develops diagnostic and prognostic tests for prostate, lung, and breast cancers that may allow physicians and patients to make more personalized treatment decisions for a better prognosis. The firm's technology is based on evidence that the immune system’s early warning signals provide critical biological insight to improve cancer detection and enhance therapeutic effectiveness. The company was founded by Eli L. Thomssen in 2008 and is headquartered in Kalamazoo, MI. | 16 jaar |
| Ned J. Kelly | M | 70 |
University of Virginia Law School Foundation
| - |
| Catherine Ann Keating | F | 61 |
University of Virginia Law School Foundation
| - |
| Catherine Lawton | F | 67 |
University of Virginia Law School Foundation
| - |
| Dennis P. Kane | M | 71 |
Armune BioScience, Inc.
Armune BioScience, Inc. Medical/Nursing ServicesHealth Services Armune BioScience, Inc. researches and develops diagnostic and prognostic tests for prostate, lung, and breast cancers that may allow physicians and patients to make more personalized treatment decisions for a better prognosis. The firm's technology is based on evidence that the immune system’s early warning signals provide critical biological insight to improve cancer detection and enhance therapeutic effectiveness. The company was founded by Eli L. Thomssen in 2008 and is headquartered in Kalamazoo, MI. | - |
| Cecil Quillen | M | - |
University of Virginia Law School Foundation
| - |
Relatiegrafiek
Connectie in verschillende bedrijven
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| Verenigde Staten | 13 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- James Sollins
- Persoonlijk netwerk
